Qingdao Baheal Pharmaceutical Holdings Limited’s Net Profit Rose 17% in 2022

Qingdao Baheal Pharmaceutical Holdings Limited (青岛百洋医药股份有限公司) (301015.SZ) reported a net profit of 485.4 million yuan in 2022, up 17% year-on-year.

Meanwhile, the company posted 7.5 billion yuan in revenue, up 6.5% year-on-year.

At the end of the reporting period, it had 5 billion yuan in total assets and 2.8 billion yuan in total liabilities, with a liability-to-asset ratio of 54.7%.